Xiaojiang Wu
- Gastroenterology top 2%
- Gastrointestinal Tumor Research and Treatment 20
- Immunology top 5%
- Oncology top 5%
- Peptidase Inhibition and Analysis 5
-
- Gastric Cancer Management and Outcomes 36
- Metastasis and carcinoma case studies 21
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 5
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 11
- Intraperitoneal and Appendiceal Malignancies 6
- Esophageal Cancer Research and Treatment 5
- Cited by
- GastroenterologyImmunologyOncology
- Journals
- Science (1 paper)Journal of Clinical Oncology (3 papers)SHILAP Revista de lepidopterología (1 paper)
In The Last Decade
Xiaojiang Wu
72 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Gastroenterology 286
- Immunology 564
- Oncology 721
- Pulmonary and Respiratory Medicine 721
- Cancer Research 288
Countries citing papers authored by Xiaojiang Wu
This map shows the geographic impact of Xiaojiang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojiang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojiang Wu more than expected).
Fields of papers citing papers by Xiaojiang Wu
This network shows the impact of papers produced by Xiaojiang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojiang Wu. The network helps show where Xiaojiang Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaojiang Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 4 | |
| 3 | 2023 | 31 | |
| 4 | 2023 | 5 | |
| 5 | A Practical Nomogram for Predicting the Prognosis of Elderly Patients with Gastric Adenocarcinoma After Gastrectomy | 2022 | 3 |
| 6 | 2022 | 5 | |
| 7 | Pan-cancer single-cell landscape of tumor-infiltrating T cellsbreakdown → | 2021 | 699 |
| 8 | 2021 | 11 | |
| 9 | 2021 | 15 | |
| 10 | 2020 | 19 | |
| 11 | 2019 | 8 | |
| 12 | 2018 | 14 | |
| 13 | 2016 | 5 | |
| 14 | 2016 | 54 | |
| 15 | 2015 | 4 | |
| 16 | 2015 | 23 | |
| 17 | 2015 | 21 | |
| 18 | 2015 | 35 | |
| 19 | 2012 | 40 | |
| 20 | 2011 | 42 |
About Xiaojiang Wu
Xiaojiang Wu is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine and Applied Microbiology and Biotechnology, having authored 75 papers that have together received 2.1k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (36 papers), Metastasis and carcinoma case studies (21 papers), Gastrointestinal Tumor Research and Treatment (20 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers), Intraperitoneal and Appendiceal Malignancies (6 papers), Esophageal Cancer Research and Treatment (5 papers), Peptidase Inhibition and Analysis (5 papers) and Cancer-related molecular mechanisms research (5 papers). The work is most often cited by research in Gastroenterology (286 citations), Immunology (564 citations) and Oncology (721 citations). Xiaojiang Wu has collaborated with scholars based in China, Ethiopia and Australia. Frequent co-authors include Zhaode Bu, Jiafu Ji, Ziyu Li, Lianhai Zhang, Xin Ji, Anqiang Wang, Aiwen Wu, Hong Zheng, Ranran Gao and Liangtao Zheng. Their work appears in journals such as Science, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.